Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

May Daher

Showing results (31-40 of 88) with videos related to

Pageof 9
Sort By:
JCO Global Oncology|March 6, 2026
Adapting Yoga Therapy to Meet the Needs of Inpatients Undergoing Hematopoietic Stem Cell Transplantation: Insights From an International, Multisite, Qualitative StudySmitha Mallaiah, Vijaya Majumdar, Scherezade K Mama, et al.
American Journal of Hematology|April 4, 2017
An exploratory clinical trial of bortezomib in patients with lower risk myelodysplastic syndromesMay Daher, Juliana Elisa Hidalgo Lopez, Jasleen K Randhawa, et al.
American Journal of Hematology|May 13, 2026
Late Cytomegalovirus Infections After Allogeneic Hematopoietic Cell TransplantGeorge L Chen, Roland Bassett, Rohtesh S Mehta, et al.
Bone Marrow Transplantation|September 19, 2023
Hematopoietic cell transplantation can be safely performed after COVID-19Alejandro Marinos, Jeremy Ramdial, Fareed Khawaja, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 9, 2024
Mortality in recipients of allogeneic haematopoietic cell transplantation in the era of cytomegalovirus primary prophylaxis: a single-centre retrospective experienceAnthony Febres-Aldana, Fareed Khawaja, Oscar Morado-Aramburo, et al.
Transplantation and Cellular Therapy|December 2, 2023
Ex Vivo Expanded Cord Blood Natural Killer Cells Combined with Rituximab and High-Dose Chemotherapy and Autologous Stem Cell Transplantation for B Cell Non-Hodgkin LymphomaYago Nieto, Pinaki Banerjee, Indresh Kaur, et al.
Transplantation and Cellular Therapy|July 27, 2025
Molecular Disparity of HY Antigen Affects Chronic Graft-Versus-Host Disease and Relapse in Female-to-Male Stem Cell TransplantsRima M Saliba, Matthias Niemann, Samer A Srour, et al.
Frontiers in Immunology|November 9, 2018
Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation After Double Cord Blood TransplantationKai Cao, David Marin, Takuye Sekine, et al.
Blood|October 21, 2016
KIR gene haplotype: an independent predictor of clinical outcome in MDS patientsKate Stringaris, David Marin, A John Barrett, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 25, 2024
Efficacy and Safety of Gilteritinib versus Sorafenib as Post-Transplant Maintenance in Patients With FLT3-ITD Acute Myeloid LeukemiaJason Yeh, Oren Pasvolsky, Rima M Saliba, et al.
Pageof 9

Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
JCO Global Oncology|March 6, 2026
Adapting Yoga Therapy to Meet the Needs of Inpatients Undergoing Hematopoietic Stem Cell Transplantation: Insights From an International, Multisite, Qualitative StudySmitha Mallaiah, Vijaya Majumdar, Scherezade K Mama, et al.
American Journal of Hematology|April 4, 2017
An exploratory clinical trial of bortezomib in patients with lower risk myelodysplastic syndromesMay Daher, Juliana Elisa Hidalgo Lopez, Jasleen K Randhawa, et al.
American Journal of Hematology|May 13, 2026
Late Cytomegalovirus Infections After Allogeneic Hematopoietic Cell TransplantGeorge L Chen, Roland Bassett, Rohtesh S Mehta, et al.
Bone Marrow Transplantation|September 19, 2023
Hematopoietic cell transplantation can be safely performed after COVID-19Alejandro Marinos, Jeremy Ramdial, Fareed Khawaja, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 9, 2024
Mortality in recipients of allogeneic haematopoietic cell transplantation in the era of cytomegalovirus primary prophylaxis: a single-centre retrospective experienceAnthony Febres-Aldana, Fareed Khawaja, Oscar Morado-Aramburo, et al.
Transplantation and Cellular Therapy|December 2, 2023
Ex Vivo Expanded Cord Blood Natural Killer Cells Combined with Rituximab and High-Dose Chemotherapy and Autologous Stem Cell Transplantation for B Cell Non-Hodgkin LymphomaYago Nieto, Pinaki Banerjee, Indresh Kaur, et al.
Transplantation and Cellular Therapy|July 27, 2025
Molecular Disparity of HY Antigen Affects Chronic Graft-Versus-Host Disease and Relapse in Female-to-Male Stem Cell TransplantsRima M Saliba, Matthias Niemann, Samer A Srour, et al.
Frontiers in Immunology|November 9, 2018
Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation After Double Cord Blood TransplantationKai Cao, David Marin, Takuye Sekine, et al.
Blood|October 21, 2016
KIR gene haplotype: an independent predictor of clinical outcome in MDS patientsKate Stringaris, David Marin, A John Barrett, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 25, 2024
Efficacy and Safety of Gilteritinib versus Sorafenib as Post-Transplant Maintenance in Patients With FLT3-ITD Acute Myeloid LeukemiaJason Yeh, Oren Pasvolsky, Rima M Saliba, et al.
Pageof 9